<DOC>
	<DOCNO>NCT01105247</DOCNO>
	<brief_summary>The purpose study establish safety efficacy orally administer PCI-32765 patient chronic lymphocytic leukemia/small lymphocytic lymphoma .</brief_summary>
	<brief_title>Safety PCI-32765 Chronic Lymphocytic Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<criteria>1 . FOR TREATMENTNAIVE GROUP ONLY : Men woman ≥ 65 year age confirm diagnosis CLL/SLL , require treatment per NCI International Working Group guideline 1518 2 . FOR RELAPSED/REFRACTORY GROUP ONLY : Men woman ≥ 18 year age confirm diagnosis relapsed/refractory CLL/SLL follow previous therapy ( ie , fail ≥ 2 previous treatment CLL/SLL least 1 regimen purine analog [ eg , fludarabine ] subject CLL ) 3 . FOR HIGHRISK RELAPSED/ REFRACTORYGROUP ONLY : Men woman ≥ 18 year age confirm diagnosis relapsed/refractory CLL/SLL suboptimal response chemoimmunotherapy , define progression disease within 24 month initiation regimen contain least nucleoside analogue bendamustine combination monoclonal antibody failure respond regimen . ( Note : minimum 2 cycle chemoimmunotherapy require eligibility ) 4 . ECOG performance status ≤ 2 5 . Willing able participate require evaluation procedure study protocol include swallow capsule without difficulty 1 . Prior malignancy , except adequately treat basal cell squamous cell skin cancer , situ cervical cancer , cancer subject disease free least 2 year limit survival &lt; 2 year 2 . Any immunotherapy , chemotherapy , radiotherapy , experimental therapy within 4 week first dose study drug ( corticosteroid diseaserelated symptom allow require 1week washout study drug administration ) 3 . Central nervous system ( CNS ) involvement lymphoma 4 . Major surgery within 4 week first dose study drug 5 . Concomitant use medicine know cause QT prolongation torsades de point 6 . Significant screen electrocardiogram ( ECG ) abnormalities include leave bundle branch block , 2nd degree AV block type II , 3rd degree block , bradycardia , QTc &gt; 470 msec 7 . Lactating pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>PCI-32765</keyword>
	<keyword>Lymphoma , B-Cell</keyword>
	<keyword>Leukemia , Lymphoid</keyword>
	<keyword>Leukemia , B-Cell</keyword>
	<keyword>Bruton 's Tyrosine Kinase</keyword>
</DOC>